"In the 10 years or so since the widespread use of B-cell depletion, there is little to suggest that a long-term paucity of B cells puts patients at risk for malignancy or opportunistic infections, nor that it leads to treatment-resistant RA or complications." (http://www.futuremedicine.com/doi/abs/10.2217/ijr.12.7?journ...)